A 58-year-old patient with type 2 diabetes presents with an HbA1c of 9.2%, elevated LDL cholesterol, decreased vibratory sensation and reflexes, and microalbuminuria. Which of the following nursing interventions is the highest priority in the management of this patient?

C) Collaborate with the healthcare provider to adjust the patient's medication regimen to improve glycemic and lipid control.

A) Educate the patient on the importance of daily foot care to prevent complications related to peripheral neuropathy.

B) Monitor the patient's blood pressure and educate on dietary changes to manage hypertension.

C) Collaborate with the healthcare provider to adjust the patient's medication regimen to improve glycemic and lipid control.

D) Encourage increased physical activity to aid in weight management and improve cardiovascular health.

A 58-year-old patient with type 2 diabetes mellitus is being evaluated by the healthcare team due to suboptimal glycemic control and elevated LDL cholesterol levels despite current treatment. Recent labs indicate an HbA1c of 9.2%, LDL cholesterol of 145 mg/dL, presence of microalbuminuria, and signs of peripheral neuropathy. Which of the following nursing interventions is most appropriate to prioritize in this patient's care plan to address these findings?

B) Collaborate with the dietitian to create a personalized meal plan focusing on low glycemic index foods.

A) Educate the patient on the importance of daily foot inspections and proper foot care.

B) Collaborate with the dietitian to create a personalized meal plan focusing on low glycemic index foods.

C) Recommend the patient increase Atorvastatin dosage before consulting the healthcare provider.

D) Advise the patient to increase physical activity to at least 150 minutes of moderate-intensity exercise per week.

A patient with type 2 diabetes presents with a decreased HbA1c level but still below target, elevated LDL cholesterol, and uncontrolled blood pressure. The patient reports worsening peripheral neuropathy symptoms despite adherence to lifestyle modifications. Which intervention should the nurse prioritize to address the patient's cardiovascular risk and neuropathy symptoms?

D) Suggest a switch to an angiotensin receptor blocker (ARB).

A) Increase the dose of the current antihypertensive medication.

B) Educate the patient on rigorous foot care practices.

C) Recommend the addition of a GLP-1 receptor agonist.

D) Suggest a switch to an angiotensin receptor blocker (ARB).

A patient with type 2 diabetes mellitus presents with a decrease in HbA1c to 8.4% but continues to have elevated LDL cholesterol and blood pressure. The patient also reports worsening peripheral neuropathy. Which of the following interventions should the nurse prioritize to address the patient's current clinical challenges and improve overall management?

B) Educate the patient about the importance of consistent foot care practices to prevent complications from peripheral neuropathy.

A) Increase the intensity of the patient's physical activity to further lower HbA1c and blood pressure.

B) Educate the patient about the importance of consistent foot care practices to prevent complications from peripheral neuropathy.

C) Suggest the addition of a glucagon-like peptide-1 (GLP-1) receptor agonist to improve glycemic control and provide cardiovascular benefits.

D) Recommend switching the antihypertensive therapy to an angiotensin receptor blocker (ARB) for renal protection.

During a follow-up appointment for a patient with type 2 diabetes, the nurse notes persistent neuropathic symptoms and increased microalbuminuria. Which of the following interventions should the nurse prioritize to address these findings?

C) Emphasize the need for protective footwear and daily foot inspections to prevent foot complications.

A) Recommend increased physical activity to improve peripheral circulation and neuropathic symptoms.

B) Educate the patient on the importance of strict glycemic control to slow the progression of microalbuminuria.

C) Emphasize the need for protective footwear and daily foot inspections to prevent foot complications.

D) Suggest the patient increase dietary protein intake to support kidney function.

A patient with type 2 diabetes presents with persistent neuropathic symptoms and worsening microalbuminuria. Which nursing intervention is most appropriate to address both symptoms and prevent further complications?

B) Educate the patient on daily foot inspections and proper footwear to prevent ulcerations.

A) Encourage the patient to increase physical activity to improve circulation.

B) Educate the patient on daily foot inspections and proper footwear to prevent ulcerations.

C) Recommend reducing dietary sodium intake to manage blood pressure.

D) Advise the patient to monitor blood glucose levels more frequently to ensure tight glycemic control.

A patient with type 2 diabetes mellitus is experiencing increased fatigue and occasional dizziness when transitioning from sitting to standing after starting an angiotensin receptor blocker. What should be the priority nursing intervention to address these symptoms?

B) Instruct the patient to perform slow transitions from sitting to standing to reduce dizziness.

A) Encourage the patient to increase salt intake to improve blood pressure stability.

B) Instruct the patient to perform slow transitions from sitting to standing to reduce dizziness.

C) Advise the patient to stop taking the angiotensin receptor blocker immediately.

D) Recommend that the patient decrease fluid intake to prevent fluid overload.

A patient with hypertension and diabetes reports increased fatigue and dizziness upon standing after starting an angiotensin receptor blocker. The patient's blood pressure averages 130/80 mmHg, but variability is noted during orthostatic measurements. What is the most appropriate nursing intervention to manage the patient's symptoms and prevent complications?

B) Educate the patient on performing slow position changes and maintaining hydration.

A) Increase the dosage of the angiotensin receptor blocker.

B) Educate the patient on performing slow position changes and maintaining hydration.

C) Discontinue the angiotensin receptor blocker and monitor blood pressure closely.

D) Suggest that the patient decrease physical activity to prevent falls.

A patient with a history of hypertension and diabetes presents with persistent fatigue, dizziness, and a newly developed foot ulcer. The healthcare team is considering changes to the patient's antihypertensive regimen due to significant postural blood pressure changes. Which nursing intervention is most appropriate to prioritize in managing this patient's current condition?

D) Coordinate with the healthcare provider to adjust antihypertensive medications to lower the risk of orthostatic hypotension.

A) Educate the patient on proper foot care and the importance of daily inspections to prevent ulcer progression.

B) Monitor the patient's blood glucose levels closely to improve glycemic control and reduce neuropathy risk.

C) Advise the patient to increase fluid intake and use compression stockings to manage orthostatic hypotension.

D) Coordinate with the healthcare provider to adjust antihypertensive medications to lower the risk of orthostatic hypotension.

A 65-year-old patient with a history of hypertension and type 2 diabetes mellitus presents with persistent fatigue, orthostatic hypotension, and a small ulcer on the left foot. The patient's blood pressure drops significantly upon standing, and there is a noted increase in HbA1c levels. Which nursing intervention is most appropriate to address the patient's orthostatic hypotension and prevent further complications?

A) Increase fluid intake and advise the patient to stand up slowly.

B) Recommend reducing antihypertensive medication dose without consulting the healthcare provider.

C) Instruct the patient to apply warm compresses to the feet daily.

D) Encourage the patient to take frequent short walks to improve circulation.

diabetes - Nursing Case Study

Pathophysiology

• Primary mechanism: In Type 1 Diabetes, the immune system mistakenly attacks and destroys insulin-producing beta cells in the pancreas, leading to an absolute insulin deficiency. Without insulin, glucose remains in the bloodstream, causing hyperglycemia.

• Secondary mechanism: In Type 2 Diabetes, there is a combination of insulin resistance, where cells fail to respond effectively to insulin, and a relative insulin deficiency due to impaired pancreatic beta-cell function. This results in inadequate glucose uptake by cells and increased blood glucose levels.

• Key complication: Persistent hyperglycemia can lead to damage of blood vessels and nerves over time, increasing the risk of cardiovascular diseases, neuropathy, and other diabetes-related complications.

Patient Profile

Demographics:

58-year-old male, truck driver

History:

• Key past medical history: Type 2 diabetes diagnosed 8 years ago, hypertension, hyperlipidemia

• Current medications: Metformin, Lisinopril, Atorvastatin, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Persistent tingling and numbness in feet

• Key symptoms: Fatigue, increased thirst, frequent urination, blurred vision, slow-healing sores

• Vital signs: Blood pressure 145/90 mmHg, heart rate 88 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F, blood glucose level 180 mg/dL

Section 1

As the healthcare team continues to assess the 58-year-old patient, new diagnostic results reveal a concerning development. Recent lab work indicates an HbA1c level of 9.2%, confirming suboptimal glycemic control over the past few months. Additionally, a lipid panel shows elevated low-density lipoprotein (LDL) cholesterol at 145 mg/dL, despite the patient's current regimen of Atorvastatin. A comprehensive foot examination uncovers decreased vibratory sensation and diminished reflexes, suggesting progression of peripheral neuropathy. Microalbuminuria is detected in a urine test, indicating early signs of diabetic nephropathy.

These findings necessitate a reevaluation of the patient's management plan. The elevated HbA1c level and lipid abnormalities highlight the need for an intensified approach to glycemic and lipid control. The healthcare team considers increasing the dosage of Metformin and possibly adding a second oral hypoglycemic agent, such as a sodium-glucose co-transporter-2 (SGLT2) inhibitor. This decision demands careful consideration of the patient's renal function, given the presence of microalbuminuria. Additionally, the persistent elevation in blood pressure necessitates an adjustment of antihypertensive therapy to better protect renal function and reduce cardiovascular risk.

The patient is educated about the importance of lifestyle modifications, including dietary changes, increased physical activity, and smoking cessation, to complement pharmacological interventions. These measures aim to mitigate the progression of complications and improve overall health outcomes. The clinical team's strategic adjustments and the patient’s adherence to the revised plan will be crucial in preventing further deterioration and enhancing quality of life. The patient is scheduled for follow-up in three months to reassess his condition and treatment efficacy, with a focus on monitoring renal function, neuropathy progression, and cardiovascular risk factors.

Section 2

Three months after the revised management plan was implemented, the patient returns for a follow-up appointment. During the initial assessment, the healthcare team notes some promising changes as well as new challenges. The patient's HbA1c has decreased to 8.4%, indicating partial improvement in glycemic control, but still not within the target range. The LDL cholesterol level has improved slightly to 130 mg/dL, yet remains above the desired threshold. Blood pressure readings are measured at 142/88 mmHg, suggesting that further optimization of antihypertensive therapy may be necessary. The patient reports adherence to the prescribed lifestyle modifications, including dietary adjustments and increased physical activity, though admits occasional difficulty with maintaining these changes consistently.

Despite some improvements, the patient's peripheral neuropathy symptoms have worsened. The patient describes an increase in burning sensations and numbness in his feet, which occasionally affects his balance. A repeat foot examination reveals further diminished vibratory sensation, prompting concerns about the risk of ulceration and potential infections. Additionally, a follow-up urine test shows a slight increase in microalbuminuria, hinting at the progression of diabetic nephropathy.

These findings necessitate further refinement of the patient's management plan. The healthcare team considers adding a glucagon-like peptide-1 (GLP-1) receptor agonist to the therapeutic regimen to enhance glycemic control and offer cardiovascular benefits. They also contemplate switching to a different class of antihypertensives that offers renal protection, such as an angiotensin receptor blocker (ARB). Moreover, the team emphasizes the need for closer monitoring of neuropathic symptoms and educates the patient about rigorous foot care practices to prevent complications. The importance of continued lifestyle modifications is reinforced, as these remain a cornerstone of managing diabetes and its complications. The patient is scheduled for another follow-up in three months, with a focus on monitoring these adjustments and their impact on his overall health.

Section 3

Three months later, the patient returns for a follow-up appointment. During the initial assessment, the healthcare team observes mixed outcomes from the recent management plan adjustments. The patient's HbA1c has decreased further to 7.9%, reflecting continued improvement in glycemic control, yet still not reaching the target of below 7%. Encouragingly, the LDL cholesterol level has dropped to 115 mg/dL, moving closer to the optimal range. Blood pressure readings now average 135/85 mmHg, indicating improved but still suboptimal control. The patient reports consistent adherence to medication and lifestyle modifications, although he mentions occasional difficulties in maintaining dietary restrictions when dining out.

Despite these positive trends, the patient's neuropathic symptoms have persisted and slightly worsened. He now experiences more frequent episodes of burning pain in his feet and reports difficulty walking longer distances due to discomfort. A detailed foot examination reveals further deterioration in vibratory sensation and the presence of a small callus on the left foot's plantar surface. Concerned about the potential for ulceration, the healthcare team emphasizes the critical importance of daily foot inspections and protective footwear.

The recent urine test results show a continued rise in microalbuminuria, with levels now reaching 80 mg/g, suggesting progressive diabetic nephropathy. This prompts the healthcare team to initiate an angiotensin receptor blocker (ARB) to provide renal protection and further manage blood pressure. The patient is educated on the signs of potential foot complications and the necessity of immediate medical attention if any changes are noted. The team stresses the importance of ongoing lifestyle adherence and schedules another follow-up in three months to assess the impact of these interventions on both his neuropathy and kidney function.

Section 4

During the follow-up appointment, the healthcare team conducts a thorough assessment of the patient's current status. The patient reports adhering to the medication regimen, including the recently added angiotensin receptor blocker, and continues to follow the recommended lifestyle modifications. Despite these efforts, the patient mentions experiencing increased fatigue and occasional dizziness, particularly when transitioning from sitting to standing, which raises concerns about possible orthostatic hypotension as a side effect of the new medication. Clinically, the patient's blood pressure now averages 130/80 mmHg, indicating further improvement, but with some variability noted during orthostatic measurements.

A comprehensive foot examination is conducted, showing persistent neuropathic symptoms with the burning sensation in the feet and reduced vibratory sensation. The callus on the left foot is carefully monitored, and no signs of ulceration are observed at this time. However, the patient admits to occasional lapses in daily foot inspections, prompting the team to reinforce the importance of consistent foot care practices. Laboratory results reveal a stable HbA1c level of 7.8%, indicating minor improvement in glycemic control, yet microalbuminuria levels have risen to 100 mg/g, suggesting ongoing renal involvement.

The healthcare team adjusts the management plan to address these developments. They recommend frequent monitoring of blood pressure at home, particularly standing measurements, to capture any significant drops that might require intervention. The patient is advised to ensure adequate hydration and to rise slowly from seated positions. To address the renal concerns, the team emphasizes strict control of blood glucose and blood pressure as paramount. A referral to a podiatrist is made to provide specialized care for the patient's feet, aiming to prevent complications such as ulceration. With these strategies in place, the team schedules another review in three months, focusing on the effectiveness of interventions and the patient's adaptation to the management plan.

Section 5

Three months later, during a follow-up appointment, the healthcare team observes a change in the patient's status. The patient reports persistent fatigue and occasional episodes of dizziness, which have become more frequent despite efforts to manage orthostatic hypotension. The blood pressure readings taken at home indicate systolic drops of up to 20 mmHg upon standing, confirming significant postural changes. Clinically, the patient's seated blood pressure remains stable at 130/80 mmHg, but standing measurements often show readings as low as 110/70 mmHg. This necessitates a reevaluation of the patient's antihypertensive regimen.

Additionally, the patient presents with a new complication: a small ulcer has developed on the left foot at the site of the previously monitored callus. On examination, the ulcer is superficial, measuring approximately 1 cm in diameter, with no signs of infection such as erythema, warmth, or purulent discharge. However, the presence of the ulcer and the patient's inconsistent foot care practices raise concerns about potential progression. The team underscores the importance of daily foot inspections and proper footwear to avoid further trauma.

Laboratory results show a slight increase in HbA1c to 8.0%, indicating a decline in glycemic control, which may be contributing to both the neuropathy and the new ulceration. Microalbuminuria remains elevated at 110 mg/g, reinforcing the need for stringent cardiovascular and renal monitoring. In response to these developments, the healthcare team decides to adjust the medication regimen by considering alternative antihypertensives with a lower risk of orthostatic hypotension and intensifying diabetes management strategies. A wound care specialist is consulted to assist in managing the foot ulcer, aiming to prevent infection and promote healing. The patient is scheduled for a follow-up in six weeks to closely monitor these interventions and make necessary adjustments.